Translational research to study the effect and mechanism of microbiota in paediatric immune-mediated diseases.

Translational research to study the effect and mechanism of microbiota in paediatric immune-mediated diseases. - Translational studies with microbiota

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30483

Enrollment

Registered

2007-05-01

Start date

2008-04-22

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immune-mediated diseases / disturbed immune system diseases

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: Child Diagnosed IMD (JCA, IDDM, AD or CD) according to international accepted standards.

Exclusion criteria

Exclusion criteria: Diseases of the blood or bloodforming organs or the immune system.

Design outcomes

Primary

Measure	Time frame
Cytokine production profile and character of immune cells of childeren with IMD exposed to several species of microbiota in vitro and in a trans-well system with humane intestinal epithelial cells.	—

Secondary

Measure	Time frame
None	—

Countries

Netherlands

Outcome results